Do positive neural IgG/IgA antibodies in serum prove autoimmune encephalitis?

Neural antibody testing can identify immune reactivity, but interpreting a positive result—especially in serum—requires clinical and laboratory context. This distinction is crucial because antibody recognition, CNS disease association, and direct pathogenicity are separate inferences.

Clinical and diagnostic evidence

• Antigen-specific neural IgG detected with a validated assay supports immune recognition of the target, particularly when reactivity is robust, reproducible, and clinically concordant. Isolated low-titre serum reactivity may be nonspecific or clinically irrelevant.
• Serum positivity alone does not diagnose autoimmune encephalitis (AE). Possible AE requires a compatible subacute syndrome (cognitive change, altered mental status, or psychiatric symptoms), at least one supportive focal neurologic, seizure, CSF, or MRI feature, and reasonable exclusion of alternatives.
• In an antibody-positive cohort, probable/definite AE or paraneoplastic neurologic syndrome occurred in 91% of CSF-only versus 31% of serum-only positive cases. Reported clinically irrelevant serum-only findings included GAD65, NMDAR, GABA-BR, Yo, and CV2.

Mechanistic interpretation

• For an antibody to directly cause CNS dysfunction, it must reach an accessible neural target within the CNS; serum detection does not show blood–brain barrier passage or intrathecal exposure.
• Stronger causal evidence comes from antigen-dependent functional effects of patient IgG—such as altered receptor/channel density, trafficking, synaptic transmission, or signaling—and ideally reproduction and reversal of effects through antigen-specific depletion or blockade.

Practical implications

• Paired serum–CSF testing and orthogonal confirmation materially improve confidence. CSF neuronal-surface antibodies generally provide stronger support for AE; however, test sensitivity is antigen-dependent (CSF is particularly important for NMDAR-IgG, while serum may be more sensitive for LGI1/CASPR2).
• Neuronal IgA results require particular caution: they are less clinically validated, may occur in healthy controls, and can reflect cross-reactivity.

Bottom line

• A positive serum neural IgG/IgA result is a contextual clue to possible immune recognition—not standalone proof of pathogenic antibodies or autoimmune encephalitis.